Filing Flows › SBC Medical Group Holdings (SBC) › Q2 2026 › vs Q1 2026
SBC Medical Group Holdings (SBC) Q2 2026 vs Q1 2026 (quarter over quarter)
SBC Medical Group Holdings's revenue rose $6.1M (+14%) from $43.1M in Q1 2026 to $49.2M in Q2 2026. Gross margin 73.1% against 70.5% (+2.7 pts).
SBC Medical Group Holdings, Q2 2026: revenue $49.2M (+13% year over year), operating margin 38.5%, net earnings $10.7M, operating cash flow $22.5M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 73.1% | 70.5% | +2.7 pts |
| Operating margin | 38.5% | 41.2% | -2.6 pts |
| Net margin | 21.7% | 26.3% | -4.5 pts |
| Free cash flow margin | 45.6% | 21.1% | +24.4 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $49.2M | $43.1M | $6.1M | +14% |
| Gross profit | $36.0M | $30.3M | $5.6M | +19% |
| Cost of revenue | $13.2M | $12.7M | $497K | +4% |
| Operating profit | $19.0M | $17.7M | $1.2M | +7% |
| Operating expenses | $17.0M | $12.6M | $4.4M | +35% |
| Pre-tax earnings | $19.0M | $18.9M | $129K | +0.7% |
| Net earnings | $10.7M | $11.3M | −$615K | -5% |
| Minority interests | $469K | $21K | $449K | 22× |
| Income tax | $7.8M | $7.5M | $296K | +4% |
| Depreciation & amortization | $1.1M | $670K | $462K | +69% |
| Working capital & other | $10.7M | −$2.7M | $13.4M | — |
| Operating cash flow | $22.5M | $9.2M | $13.3M | +144% |
| Free cash flow (OCF − capex) | $22.4M | $9.1M | $13.3M | +146% |
| Capital expenditures | $84K | $125K | −$41K | -32% |
Questions
How much did SBC Medical Group Holdings's revenue grow quarter over quarter in Q2 2026?
SBC Medical Group Holdings's revenue rose $6.1M (+14%) from $43.1M in Q1 2026 to $49.2M in Q2 2026. Gross margin 73.1% against 70.5% (+2.7 pts).